The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5041730 6080360 I 5041730-0 20060401 20060621 20060630 EXP HQWYE339822JUN06 WYETH PHARMACEUTICALS INC. 13 YR F N 20060629 UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5041730 1007435634 PS PREMARIN 1 ORAL 0.625 MG 1X PER 1 DAY, ORAL D D 4782

Indications of drugs used

Event ID DRUG SEQ INDI PT
5041730 1007435634 OESTROGEN REPLACEMENT THERAPY

Outcome of event

Event ID OUTC COD
5041730 HO

Reactions reported

Event ID PT
5041730 ABDOMINAL DISTENSION
5041730 BLOOD ALBUMIN DECREASED
5041730 OEDEMA PERIPHERAL

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
5041730 CSM

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5041730 1007435634 20041201 20060529